Literature DB >> 11251971

Gene expression profiling of malignant mesothelioma cell lines: cDNA array study.

E Kettunen1, A M Nissén, T Ollikainen, M Taavitsainen, J Tapper, K Mattson, K Linnainmaa, S Knuutila, W El-Rifai.   

Abstract

To reveal genes relevant for malignant mesothelioma (MM), we carried out cDNA array experiments on 4 MM cell lines and 2 primary mesothelial cell cultures established from pleural fluid of non-cancer patients. Human cancer gene filters including 588 genes were used for the cDNA array experiments. Our study revealed 26 over-expressed genes that play a role in the regulation of cell fate, cell cycle, cell growth and DNA damage repair and 13 under-expressed genes encoding growth factors, receptors and proteins involved in cell adhesion, motility and invasion to be common to 3 or 4 MM cell lines. We confirmed the cDNA array results using RT-PCR for 5 of the over-expressed genes and for 3 of the under-expressed genes. Our study presents gene expression profiles in MM cell lines and shows the involvement of several genes, such as those encoding JAGGED1, ser/thr protein kinase NIK, Ku80 and cyclin D2, novel in MM. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11251971     DOI: 10.1002/1097-0215(200002)9999:9999<::aid-ijc1094>3.0.co;2-m

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  11 in total

Review 1.  Cellular and molecular parameters of mesothelioma.

Authors:  Maria E Ramos-Nino; Joseph R Testa; Deborah A Altomare; Harvey I Pass; Michele Carbone; Maurizio Bocchetta; Brooke T Mossman
Journal:  J Cell Biochem       Date:  2006-07-01       Impact factor: 4.429

2.  Identification of novel candidate oncogenes and tumor suppressors in malignant pleural mesothelioma using large-scale transcriptional profiling.

Authors:  Gavin J Gordon; Graham N Rockwell; Roderick V Jensen; James G Rheinwald; Jonathan N Glickman; Joshua P Aronson; Brian J Pottorf; Matthew D Nitz; William G Richards; David J Sugarbaker; Raphael Bueno
Journal:  Am J Pathol       Date:  2005-06       Impact factor: 4.307

Review 3.  Overexpressed genes in malignant pleural mesothelioma: implications in clinical management.

Authors:  Elisa Barone; Federica Gemignani; Stefano Landi
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

4.  Genome-wide profile of pleural mesothelioma versus parietal and visceral pleura: the emerging gene portrait of the mesothelioma phenotype.

Authors:  Oluf Dimitri Røe; Endre Anderssen; Eli Helge; Caroline Hild Pettersen; Karina Standahl Olsen; Helmut Sandeck; Rune Haaverstad; Steinar Lundgren; Erik Larsson
Journal:  PLoS One       Date:  2009-08-07       Impact factor: 3.240

Review 5.  Making the case for molecular staging of malignant pleural mesothelioma.

Authors:  Raphael Bueno
Journal:  Semin Thorac Cardiovasc Surg       Date:  2009

Review 6.  Biomarkers for malignant pleural mesothelioma: current status.

Authors:  Laurent Greillier; Paul Baas; John J Welch; Baktiar Hasan; Alexandre Passioukov
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

Review 7.  Current therapy for malignant mesothelioma.

Authors:  W Roy Smythe
Journal:  Curr Oncol Rep       Date:  2002-07       Impact factor: 5.945

8.  Gene expression profiles of bladder cancers: evidence for a striking effect of in vitro cell models on gene patterns.

Authors:  V Dangles; V Lazar; P Validire; S Richon; M Wertheimer; V Laville; J-L Janneau; M Barrois; C Bovin; T Poynard; G Vallancien; D Bellet
Journal:  Br J Cancer       Date:  2002-04-22       Impact factor: 7.640

Review 9.  Switching off malignant mesothelioma: exploiting the hypoxic microenvironment.

Authors:  Noushin Nabavi; Kevin L Bennewith; Andrew Churg; Yuzhuo Wang; Colin C Collins; Luciano Mutti
Journal:  Genes Cancer       Date:  2016-11

10.  Long non coding RNAs (lncRNAs) are dysregulated in Malignant Pleural Mesothelioma (MPM).

Authors:  Casey M Wright; Michaela B Kirschner; Yuen Yee Cheng; Kenneth J O'Byrne; Steven G Gray; Karin Schelch; Mir Alireza Hoda; Sonja Klebe; Brian McCaughan; Nico van Zandwijk; Glen Reid
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.